Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy - Concepedia

Concepedia

Publication | Open Access

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

DOI Full Paper Access

108

Citations

38

References

2023

Year

Gloria Iacoboni, Vı́ctor Navarro, Ana África Martín‐López, Kai Rejeski, Mi Kwon, Katarzyna Aleksandra Jalowiec, Paula Amat, Juan Luis Reguera, Laura Gallur, Viktoria Blumenberg,

Journal of Clinical Oncology

Abstract

Recent bendamustine exposure before apheresis was associated with negative treatment outcomes after CD19-targeted CAR T-cell therapy and should be therefore avoided in CAR T-cell candidates.

References

	Year	Citations

Page 1